Eli Lilly's Cymbalta 'Poison,' Ex-User Says In Bellwether

Law360, Los Angeles (August 5, 2015, 9:48 PM EDT) -- A woman alleging Eli Lilly & Co. concealed the withdrawal risks of its antidepressant Cymbalta on Wednesday took the stand in the bellwether trial in California federal court and testified that had she known the risks, she would not have taken the drug, which she labeled a "poison."

Plaintiff Claudia Herrera is one of hundreds of plaintiffs who have filed suit in state and federal court against the drugmaker, one of her attorneys, Brent Wisner of Baum Hedlund Aristei & Goldman PC, told Law360 on Tuesday, and her case is the first of the federal suits to reach a jury. Another...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!